Immunoblotting revealed a significant decrease of Ser396 phosphorylation of tau and an increase of FZD3 and H3K27Ac levels in the hippocampi of MET-treated AD mice (Figure 6D). The gene discussed is FZD3; the disease is Alzheimer disease.